Oculogica
PrivateLast Round
Series B
May 13, 2024
Est. Valuation
$51.62M
Total Funding Raised
$23.35M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Oculogica is a neuro-diagnostic company that develops and commercializes eye-tracking medical devices for the objective assessment of concussions and other brain injuries.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oculogica Comparables
Compare Oculogica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BrainScope | 88% | |
| NeuroSync | 85% | |
| RightEye | 83% | |
Oculogica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 13, 2024 | ||||
| Grant | May 18, 2021 | ||||
| Series A | Jan 16, 2020 | ||||
| Grant | Jun 1, 2018 | ||||
| Seed | Jul 16, 2014 | ||||
Angel | May 20, 2014 |
Key People
Founding team and executive leadership
Oculogica Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Sofia Fund | Series A |
| U.S. Army Medical Research and Development Command | Grant |
| TitletownTech | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Monthly visitors increased 42% MoM.
- May 18, 2021
$2M grant from U.S. Army Medical Research and Development Command.
Oculogica Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Oculogica's valuation, stock price, and market status.